QUETIAPINE XR : Affected lots may exceed the established… recall
QUETIAPINE XR : Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)
- Published
- 7 Jan 2025
- Agency
- Health Canada
- Country
- Canada
The hazard
Product quality
Classification: Type I
What to do
Verify if your product is affected. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Source: Health Canada, published 7 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.